Clinical Trials Logo

Eosinophilic Duodenitis clinical trials

View clinical trials related to Eosinophilic Duodenitis.

Filter by:
  • Withdrawn  
  • Page 1

NCT ID: NCT05152563 Withdrawn - Clinical trials for Eosinophilic Gastritis

A Study to Assess Subcutaneous AK002 in Eosinophilic Gastritis and/or Eosinophilic Duodenitis

ENIGMA-SC
Start date: December 2021
Phase: Phase 3
Study type: Interventional

This is a Phase 3, multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy, safety, tolerability, and pharmacodynamic effect of subcutaneous lirentelimab (AK002), given monthly for 6 doses, in subjects with moderate to severe Eosinophilic Gastritis and/or Eosinophilic Duodenitis who have an inadequate response with, lost response to, or were intolerant to standard therapies.